TRCT
VKTXW

Tower Research Capital (TRC)’s Viking Therapeutics, Inc. VKTXW Stock Holding History

Tower Research Capital (TRC)’s Portfolio VKTXW Stock Details VKTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed – – 4280
2018
Q1 		$0 Buy
+100
New +$409 ﹤0.01% 4105

Other funds holding VKTXW

William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Tower Research Capital (TRC)'s VKTXW Position: Q2 2018 in Review

Tower Research Capital (TRC) sold out of Viking Therapeutics, Inc. (VKTXW) in Q2 2018, closing a stake of 100 shares.

Tower Research Capital (TRC) first reported a position in VKTXW in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 4 funds tracked by Wall St. Rank hold VKTXW as of Q2 2018.

  • Tower Research Capital (TRC) reported no remaining Viking Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 Viking Therapeutics, Inc. shares in Q2 2018.
  • Tower Research Capital (TRC) first reported a position in Viking Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Viking Therapeutics, Inc. position peaked at $0 in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q2 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.